The antagonizing activity of a novel peptide analogs, iQWcF, on the function of endothelin receptors / 中国药理学通报
Chinese Pharmacological Bulletin
;
(12): 302-304, 2002.
Article
in Chinese
| WPRIM
| ID: wpr-857491
ABSTRACT
AIM:
To evaluate the antagonizing activity of iQWcF, a modified tripeptide, to endothelin receptors.METHODS:
1 Vasoconstriction experiments with aorta strips of rats. 2 In vivo experiments male normotensive Wistar rats were anesthetized with pentobarbital-Na (50 mg·kg-1), and catheterized into the carotic artery for measurement of blood pressure, and into the femoral vein for administration of iQWcF (30 mg·kg-1) and ET-1(0.9 nmol ·kg-1). The test compound was given intravenously 5 min before the bolus injection of ET-1. Control animals received saline on the same time schedule. The blood pressure was recorded at different time interval after injecting ET-1.RESULTS:
1iQWcF prohibited the vascontriction of aorta induced by ET-1 in a concentration-dependent fashion. 2 The compound (30 mg·kg-1. iv) markedly antagonized ET-1-induced the long-lasting pressor phase mediated by ETA without affecting early transient depressor phase by ETB.CONCLUSION:
iQWcF is one of ETA-selective antagonists.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Pharmacological Bulletin
Year:
2002
Type:
Article
Similar
MEDLINE
...
LILACS
LIS